ISSN 2398-2950      

Mast cell tumor: chemotherapy protocols

ffelis

Introduction

  • The following chemotherapy protocols for mast cell tumors will be covered:
    • Protocol 1: Vinblastine/prednisolone protocol.
    • Protocol 2: CCNU + prednisolone.
    • Protocol 3: Tyrosine kinase inhibitors (TKI). 

Protocols are not listed in order of preference or efficacy.Do not use without consulting specialist oncologist.Refer to chemotherapy safety administration Chemotherapy: safe handling.

Protocol 1

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 2

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 3

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Legal and safety precautions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Berger E P, Johannes C M, Post G S, Rothchild G, Shiu K B, Wetzel S, Fox L E (2018) Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia. J Feline Med Surg 20(2), 95-102 PubMed.
  • Harper A, Blackwood L (2017) Toxicity and response in cats with neoplasia treated with toceranib phosphate. J Feline Med Surg 19 (6), 619-623 PubMed.
  • Musser M L, Quinn H T, Chretin J D (2012) Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats. J Feline Med Surg 14(12), 871-875 PubMed.
  • Rassnick K M, Williams L E, Kristal O et al (2008) Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). J Am Vet Med Assoc 232 (8), 1200-1205 PubMed.
  • Lachowicz  J L, Post G S, Brodsky E (2005) A Phase I Clinical Trial Evaluating Imatinib Mesylate (Gleevec) in Tumor‐Bearing Cats. J Vet Intern Med 19 (6), 860-864 PubMed.
  • Graham-Mize C A,  Rosser E  J (2004) Bioavailability and activity of
    prednisone and prednisolone in the feline patient.
    Vet Dermatol 15 (Suppl 1), 9-10.
  • Fan T M, Kitchell B E, Dhaliwal R S et al (2002) Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen. J Am Anim Hosp Assoc 38 (4), 357-363 PubMed.
  • Rassnick K M, Gieger T L, Williams L E et al (2001) Phase I evaluation of CCNU (lomustine) in tumor-bearing cats. J Vet Intern Med 15 (3), 196-199 PubMed.
  • Rassnick K M, Moore A S, Williams L E et al (1999) Treatment of mast cell tumors with CCNU (lomustine). J Vet Intern Med 13 (6), 601-605 PubMed.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!